Skip to main navigation Skip to search Skip to main content

JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models

Research output: Contribution to journal › Article › peer-review

89   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'JAK/STAT inhibition with ruxolitinib enhances oncolytic virotherapy in non-small cell lung cancer models'. Together they form a unique fingerprint.
Sort by

Keyphrases

Immunology and Microbiology